SHK-loaded colloidal mesoporous silica nanoparticles selectively deliver inhibitors to CRC cells, effectively suppressing PKM2 activity and aerobic glycolysis, thereby inhibiting tumor proliferation (87). Here, PKM is linked to neoplasm.